Chartwell Investment Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $515K | Buy |
18,085
+144
| +0.8% | +$4.1K | 0.02% | 399 |
|
|
2024
Q2 | $474K | Sell |
17,941
-2,924
| -14% | -$77.3K | 0.02% | 397 |
|
|
2024
Q1 | $674K | Buy |
20,865
+495
| +2% | +$16K | 0.02% | 390 |
|
|
2023
Q4 | $858K | Sell |
20,370
-2,756
| -12% | -$116K | 0.03% | 374 |
|
|
2023
Q3 | $887K | Hold |
23,126
| – | – | 0.03% | 361 |
|
|
2023
Q2 | $439K | Buy |
23,126
+1,122
| +5% | +$21.3K | 0.02% | 393 |
|
|
2023
Q1 | $341K | Buy |
22,004
+739
| +3% | +$11.5K | 0.01% | 398 |
|
|
2022
Q4 | $377K | Buy |
+21,265
| New | +$377K | 0.01% | 390 |
|